XEN.AU Xenitra Limited
- Market cap
- AUD 9.39M
- P/E
- -
- P/B
- 37.26x
- ROE
- -2,056.0%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is XEN.AU undervalued?
Graham numberThe Graham number of Xenitra Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Xenitra Limited fundamental analysis
4 of 21 checks passedROE 0/2
Low return on equity (-2,056.0%), below 10%.
ROA 0/1
Return on assets (-116.7%) is below the industry median (14.2%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-9.4%) is below the industry median (11.6%).
Revenue Growth 2/2
Revenue grew 96.0% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (481.0%), above 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Cash covers 2.8 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (37.3x) is above the industry median (11.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Xenitra Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Xenitra Limited
Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care prod…
Full company profileXenitra Limited financial statements
Xenitra Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.19M | 21.4M | 44.3M | 60.1M | 12.4M | 6.01M | 2.67M | 25.9M | 39.8M | 20.1M |
| Gross Profit | -335K | 3.14M | 7.63M | 25.3M | 1.78M | -3.61M | 60.2K | 844K | 969K | -2.25M |
| Operating Income | -895K | -8.80M | -7.91M | -5.76M | -9.33M | -4.82M | -2.57M | -2.43M | -3.48M | -5.55M |
| EBITDA | -30.6K | -9.08M | -7.33M | -2.14M | -19.7M | -4.78M | -2.11M | -5.85M | -3.39M | -5.47M |
| Net Income | -254K | -11.2M | -7.76M | -5.15M | -20.1M | -6.07M | -3.03M | -6.28M | -3.48M | -5.18M |
| EPS | 0.00 | -0.06 | -0.03 | -0.02 | -0.04 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 5.66M | 20.5M | 22.4M | 45.4M | 17.3M | 10.1M | 6.37M | 4.37M | 8.30M | 4.44M |
| Total Liabilities | 4.16M | 3.35M | 4.59M | 29.4M | 12.0M | 5.98M | 1.26M | 3.80M | 5.64M | 4.26M |
| Shareholders' Equity | 1.51M | 17.2M | 17.8M | 16.0M | 5.39M | 4.18M | 5.11M | 525K | 2.55M | 252K |
| Cash & Short-term Investments | 1.13M | 10.7M | 10.0M | 8.23M | 4.26M | 3.04M | 1.55M | 2.03M | 1.72M | 3.16M |
| Total Debt | 2.61M | 190K | 129K | 15.6M | 3.06M | 520K | - | 2.19M | 1.16M | 1.21M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -848K | -7.33M | -5.95M | 3.01M | -7.99M | -4.64M | -3.46M | -2.65M | -4.26M | -1.13M |
| Capital Expenditure | 3.00 | 2.42M | 674K | 5.92M | 2.49M | 713K | 1.00 | 190K | 6.90K | 8.00K |
| Free Cash Flow | -848K | -9.75M | -6.63M | -2.92M | -10.5M | -5.35M | -3.46M | -2.84M | -4.26M | -1.14M |
| Ratios | ||||||||||
| ROE | -16.9% | -65.3% | -43.5% | -32.1% | -373.5% | -145.4% | -59.3% | -1,197.4% | -136.7% | -2,056.0% |
| ROA | -4.5% | -54.7% | -34.6% | -11.3% | -116.1% | -60.3% | -47.5% | -143.9% | -41.9% | -116.7% |
| Net Profit Margin | -21.3% | -52.5% | -17.5% | -8.6% | -161.7% | -101.0% | -113.4% | -24.3% | -8.8% | -25.8% |
| Debt to Equity | 1.73x | 0.01x | 0.01x | 0.97x | 0.57x | 0.12x | - | 4.18x | 0.46x | 4.81x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Xenitra Limited dividends
Xenitra Limited has not paid dividends in the last 10 fiscal years.
Last stock split: 1:6 on Sep 14, 2017.
Who owns Xenitra Limited
- Insiders 34.09%
- Institutions 2.99%
- Public & others 62.92%
- Shares outstanding 4.69B
- Free float 2.19B
Xenitra Limited company profile
- Company name
- Xenitra Limited
- Ticker
- XEN.AU
- ISIN
- AU0000460198
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Cyclical
- Industry
- Department Stores
- Fiscal year end
- June
- Address
- 270 Adelaide Street, Brisbane, QLD, Australia, 4000
- Phone
- 61 1800 800 285
- Website
- xenitra.com
About Xenitra Limited
Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritional product trading. It sells its products through a network of B2B wholesale, retail distribution, and e-commerce platforms. The company was formerly known as AuMake Limited and changed its name to Xenitra Limited in March 2026. Xenitra Limited was incorporated in 2011 and is based in Brisbane, Australia.
Xenitra Limited management
4- Ms. Zhao ZhangHead of China
- Mr. Zhiguo ZhangGroup Chief Operating Officer
- Mr. Sebastian AndreCompany Secretary
- Mr. Chen ZhenghaiGroup General Manager